RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,595 | +6.4% | 1,901 | +19.7% | 0.00% | +100.0% |
| Q2 2023 | $29,696 | +1.9% | 1,588 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $29,140 | -7.3% | 1,588 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $31,442 | -17.7% | 1,588 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $38,207 | +31.8% | 1,588 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $28,981 | +4.8% | 1,588 | +26.3% | 0.00% | 0.0% |
| Q1 2022 | $27,641 | -85.9% | 1,257 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $195,661 | +18.3% | 5,327 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $165,403 | -2.3% | 5,327 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $169,345 | +42.6% | 5,327 | +44.4% | 0.00% | 0.0% |
| Q3 2020 | $118,754 | +11.0% | 3,688 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $107,026 | – | 3,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |